Sign in

CIK 0001754068

  • Non-accelerated filer
  • Smaller reporting company

Kalaris Therapeutics, Inc.

Sign in to watch
Ticker
KLRS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
831971007
Phone
+1 650-249-2727
Business address
400 CONNELL DRIVE, SUITE 5500, BERKELEY HEIGHTS, NJ, 07922
Former names
Allovir, Inc., ViraCyte, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-06-03 ADAMIS ANTHONY P Director Grant or award · Stock Option (Right to Buy) +9,000 9,000
2025-04-10 ADAMIS ANTHONY P Director Grant or award · Stock Option (Right to Buy) +18,000 18,000
2025-03-18 ADAMIS ANTHONY P Director Grant or award · Stock Option (right to buy) +19,484 19,484
2025-03-18 ADAMIS ANTHONY P Director Grant or award · Stock Option (right to buy) +12,989 12,989

Page 1 of 1 · 4 trades